Biobot Analytics

Challenger

Company Overview

$20M Series A Oct 2021 (Thursday Ventures/YC); MIT spinoff; CDC NWSS 2021; 300+ facilities; 3-week hospitalization lead time; NIDA drug program; YC

Revenue
$20M
Last updated: January 1, 2024
Loading News...
Loading Timeline...
Loading Culture...
Loading Leadership...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Strong Challenger

Biobot Analytics is an established challenger with significant market presence and competitive offerings in Government Tech.

Frequently Asked Questions

AI Visibility Rankings

How Biobot Analytics performs in AI search results

AI Rank
?
Track your position
Platforms
5
ChatGPT, Gemini, Claude...
Visibility
?
Your mention rate
Premium Feature

Unlock AI Visibility Tracking for Biobot Analytics

See exactly how Biobot Analytics ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.

Real-time Rankings
Track your position daily
Competitive Intel
See how you compare
Platform Breakdown
Per-AI performance
Actionable Insights
Optimize your visibility
Start Tracking for Free

Join 1,000+ brands · Free 7-day trial · No credit card required

Want to improve your AI visibility? Track performance across all major AI platforms.
Compare with Other Brands

Compare with Other Brands

See how Biobot Analytics stacks up against competitors with our detailed comparison tool.

Start Comparison